Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × tremelimumab × Gastrointestinal × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 9 Fluorouracil 8 Oxaliplatin 6 Nivolumab 6 Leucovorin 6 Sorafenib 5 Ipilimumab 5 Cetuximab 5 Bevacizumab 5 Irinotecan 4 Cisplatin 4 Capecitabine 4 trifluridine tipiracil drug combination 3 trastuzumab deruxtecan 3 cabozantinib 3 zolbetuximab 2 selpercatinib 2 lenvatinib 2 encorafenib 2 durvalumab 2 Paclitaxel 2 HMPL-013 2 Gemcitabine 2 Docetaxel 2 zenocutuzumab 1 tucatinib 1 tremelimumab 1 trametinib 1 toripalimab 1 sotorasib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03298451 2026-01-14

HIMALAYA

AstraZeneca

Phase 3 Active not recruiting

1,324 enrolled 31 charts 1 FDA

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡